SCHEDULE: Blue Owl Capital Holdings LP Files Schedule 13G

Blue Owl Capital Holdings LP has filed an amendment to its Schedule 13G, reporting zero beneficial ownership of Repare Therapeutics Inc. common shares as of March 31, 2026.

Summary

• Blue Owl Capital Holdings LP has filed an amendment (Amendment No. 2) to its Schedule 13G filing.
• The filing pertains to Repare Therapeutics Inc. common shares.
• As of the event date, March 31, 2026, Blue Owl Capital Holdings LP reports 0.00 shares beneficially owned.
• This represents 0.00% of the class of securities.
• The reporting person has 0.00 sole voting power, 0.00 shared voting power, 0.00 sole dispositive power, and 0.00 shared dispositive power.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports a change in reporting status with zero beneficial ownership, rather than providing operational or financial performance updates.

Future Outlook

N/A

Industry Context

StockSavvy.ai notes that Schedule 13G filings are typically made by institutional investors who acquire beneficial ownership of more than 5% of a class of a company's registered equity securities. A filing reporting zero ownership suggests a divestment or a change in reporting status.

Key Dates

Keywords

Schedule 13G, SEC Filing, Blue Owl Capital Holdings LP, Repare Therapeutics Inc., Beneficial Ownership, Securities Exchange Act of 1934, Common Shares